Av. rating

When reality exceeds expectations: Results of 3 farms which used a vaccine against bovine mastitis

During the last edition of the EBF (Eurpean Buiatrics Forum 2019) different examples of the ROI (return on investment) that a dairy farm can expect when implementing preventive measures against bovine mastitis were shared. In particular, results of vaccination were one of the most surprising ones, as one of the farms was able to achieve a saving of more than € 6,800 after vaccination.

Hans Caron is a veterinarian from the Netherlands who has spent years trying to find the most cost-effective measures for his clients with dairy farms.

At the most recent EBF (European Buiatrics Forum), Dr. Caron presented the results obtained with the SimHerd® simulation platform, which showed the return on investment of various measures to prevent bovine mastitis, including vaccination with the vaccine STARTVAC®.

TABLE 1: Results for Farm 1, where a saving of € 44 per cow was achieved

 

Under the title: “Economic evaluation of bovine mastitis vaccination based on Simherd modelling”, Dr. Caron presented 3 different scenarios, which he had analysed beforehand using the program.

On the first farm (see table 1, around 120 cows, 28L/day, BSCC 250.000, with aureus problems and vaccinating since 2014), he noted how the true scenario greatly surpassed its simulated values, exceeding the estimates relating to clinical bovine mastitis and SCC (Somatic Cell Count), meaning a saving of € 44 per cow.

Vaccination against Bovine Mastitis: Calculation of the Return on Investment in farm 2.TABLE 2: Results for Farm 2, where a saving of € 61 per cow was achieved.

 

In another scenario, with fewer than 80 cows, and 35L/day, using STARTVAC® vaccine against mastitis in cattle since 2016 and a predominant pathogen which was E. coli, a reduction could be seen in the risk of suffering from bovine mastitis, giving a saving of 61 € per animal.

Vaccination against Bovine Mastitis: Calculation of the Return on Investment in farm 3.TABLE 3: Results for Farm 3, where a saving of € 62 per cow was achieved.

 

In the case of the final farm, with a hundred animals and where the predominant pathogen was Staph. aureus, a saving of € 6,400 was predicted on the farm and the actual value achieved was € 6,804 (€ 400 extra).

These scenarios show that prevention always has a much greater return than treatment.

We will continue to share more experiences with the success of vaccination.

How useful was this information for you?:

[Total: 1   Average: 5/5]

RELATED POSTS

NEWSLETTER

DON’T MISS ANY UPDATES ON MASTITIS VACCINATION

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Mastitis Vaccination to ask any questions or discuss any concerns you may have about mastitis.


      I have read and agree to the Privacy Policy and Basic information on Data Protection.


      DISCOVER THE QUICK TALKS !

      Subscribe to our newsletter and be updated with the latest STREAMING COURSES & VIDEO-WEBINARS on bovine mastitis!


        I have read and agree to the Privacy Policy and Basic information on Data Protection.

        Basic Personal Data Protection information: Controller: LABORATORIOS HIPRA, S.A. Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA. Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest. Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group. Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy. For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.